Turenne Santé has made its first European investment by acquiring a stake in Italian respiratory diagnostics leader MIR, alongside Quadrivio, signaling a strategic expansion into the growing health sector.

Target Company Overview

Founded in 1993 and headquartered in Rome, MIR (Medical International Research) is a leading international player in the field of spirometry. The company specializes in early diagnosis and monitoring of respiratory conditions through an integrated diagnostic platform that includes medical devices such as spirometers, oximeters, and single-use respiratory turbines, complemented by proprietary software for real-time monitoring of vital signs.

MIR operates in over 100 countries and has established a robust distribution network, which includes subsidiaries in North America, France, and Brazil. The company aims to expand its presence into strategic markets and embark on a new phase of growth as it seeks to enhance its product offerings and develop further acquisitions.

Industry Overview in Italy

Italy's medical devices industry is characterized by a strong emphasis on innovation and quality, with an increasing focus on technological advancements in healthcare. The sector h